J. Berbis,

L. ,

M. Bénédicte, MCF)(06ème section) TANTI-HARDOUIN Nicolas (PRAG) IMMUNOLOGIE 4703 HEMATOLOGIE, TRANSFUSION, vol.4701

K. Gilles, PU-PH) BLAISE Didier

M. Jean-louis, PU-PH) COSTELLO Régis

O. Daniel, PU-PH) CHIARONI Jacques

E. Vivier,

G. ,

M. Pierre-emmanuel,

. Feron-françois, PR) (69ème section) VEY Norbert

B. Joseph,

G. Véronique,

D. Joëlle,

L. Marina,

D. Sophie, MCU-PH) LOOSVELD Marie

R. Philippe,

. Vely-frédéric, MCU-PH) POGGI Marjorie (MCF) (64ème section)

;. Boucault/garrouste-françoise and . Sante, MCF) 65ème section

L. Georges,

, MALADIES INFECTIEUSES

, MALADIES TROPICALES 4503 PELISSIER/ALICOT Anne-Laure

P. ,

. Brouqui-philippe,

L. Jean-christophe, PU-PH) BARTOLI Christophe

(. Parola-philippe and . Lucile,

. Stein-andréas,

B. Caroline, MCF) (1ère section) MILLION Matthieu

C. Brun-buisson, P. Meshaka, and P. Pinton, « EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units, Intensive Care Med, vol.30, issue.4, pp.580-588, 2004.

D. W. Landry and J. A. Oliver, « The pathogenesis of vasodilatory shock, N. Engl. J. Med, vol.345, issue.8, pp.588-595, 2001.

M. Singer, C. S. Deutschman, and C. W. Seymour, The Third International Consensus Definitions for Sepsis and Septic Shock, vol.315, pp.801-810, 2016.

A. Rhodes, L. E. Evans, and E. W. Alhazzani, « Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock, Intensive Care Med, vol.43, issue.3, pp.304-377, 2016.

D. D. Backer, C. Aldecoa, and H. Njimi, « Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis* », Crit. Care Med, vol.40, issue.3, pp.725-730, 2012.

K. Takakura, T. Taniguchi, and E. I. Muramatsu, « Modification of alpha1-adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis, Crit. Care Med, vol.30, issue.4, pp.894-899, 2002.

C. Martin, S. Medam, F. Antonini, «. Too-much, and T. Long, Shock Augusta Ga, vol.44, issue.4, pp.305-309, 2015.

A. W. Cowley, E. Monos, and A. C. Guyton, « Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog », Circ. Res, vol.34, issue.4, pp.505-514, 1974.

L. G. Hall, L. J. Oyen, and C. B. Taner, « Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock, Pharmacotherapy, vol.24, issue.8, pp.1002-1012, 2004.

A. Polito, E. Parisini, and E. Z. Ricci, « Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis », Intensive Care Med, vol.38, issue.1, pp.9-19, 2012.

D. W. Landry, H. R. Levin, and E. M. Gallant, « Vasopressin deficiency contributes to the vasodilation of septic shock, Circulation, vol.95, issue.5, pp.1122-1125, 1997.

T. Sharshar, A. Blanchard, and E. M. Paillard, « Circulating vasopressin levels in septic shock, Crit. Care Med, vol.31, issue.6, pp.1752-1758, 2003.

S. Jochberger, J. Dörler, and G. Luckner, « The vasopressin and copeptin response to infection, severe sepsis, and septic shock, Crit. Care Med, vol.37, issue.2, pp.476-482, 2009.

I. Lin, H. Ma, A. C. , and -. Lin, Low plasma vasopressin/norepinephrine ratio predicts septic shock », Am. J. Emerg. Med, vol.23, issue.6, pp.718-724, 2005.

T. Sharshar, R. Carlier, and E. A. Blanchard, « Depletion of neurohypophyseal content of vasopressin in septic shock, Crit. Care Med, vol.30, issue.3, pp.497-500, 2002.

D. W. Landry, H. R. Levin, and E. M. Gallant, « Vasopressin pressor hypersensitivity in vasodilatory septic shock, Crit. Care Med, vol.25, issue.8, pp.1279-1282, 1997.

A. O'brien, L. Clapp, and E. M. Singer, « Terlipressin for norepinephrine-resistant septic shock, Lancet Lond. Engl, vol.359, pp.1209-1210, 2002.

F. Lauzier, B. Lévy, and P. Lamarre, « Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial, Intensive Care Med, vol.32, issue.11, pp.1782-1789, 2006.

M. Leone and W. A. Boyle, « Decreased vasopressin responsiveness in vasodilatory septic shocklike conditions, Crit. Care Med, vol.34, issue.4, pp.1126-1130, 2006.

K. Ohsugi, T. Kotani, and E. S. Fukuda, « Does vasopressin improve the mortality of septic shock patients treated with high-dose NA », Indian J. Crit. Care Med. Peer-Rev. Off. Publ. Indian Soc. Crit. Care Med, vol.20, issue.3, pp.137-140, 2016.

A. Morelli, C. Ertmer, and E. S. Rehberg, « Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study, Crit. Care Lond. Engl, vol.13, p.130, 2009.

J. Albanèse, M. Leone, and E. A. Delmas, « Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study, Crit. Care Med, vol.33, issue.9, pp.1897-1902, 2005.

A. Morelli, C. Ertmer, M. Westphal, and «. , Terlipressin in the treatment of septic shock: the earlier the better, Best Pract. Res. Clin. Anaesthesiol, vol.22, issue.2, pp.317-321, 2008.

M. Leone, J. Albanèse, and E. A. Delmas, « Terlipressin in catecholamine-resistant septic shock patients, Shock Augusta Ga, vol.22, issue.4, pp.314-319, 2004.

A. E. Jones, S. Trzeciak, and J. A. Kline, « The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation, Crit. Care Med, vol.37, issue.5, pp.1649-1654, 2009.

F. L. Ferreira, D. P. Bota, and E. A. Bross, « Serial evaluation of the SOFA score to predict outcome in critically ill patients, JAMA, vol.286, issue.14, pp.1754-1758, 2001.

R. Moreno, J. L. Vincent, and E. R. Matos, « The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM », Intensive Care Med, vol.25, issue.7, pp.686-696, 1999.

H. B. Nguyen, E. P. Rivers, and B. P. Knoblich, « Early lactate clearance is associated with improved outcome in severe sepsis and septic shock, Crit. Care Med, vol.32, issue.8, pp.1637-1642, 2004.

J. A. Kellum, N. Lameire, and K. Aki, Guideline Work Group, « Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary, Crit. Care Lond. Engl, vol.17, issue.1, p.204, 2013.

R. L. Mehta, J. A. Kellum, and S. V. Shah, Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury, vol.11, p.31, 2007.

P. R. Rosenbaum and D. B. Rubin, « The Central Role of the Propensity Score in Observational Studies for Causal Effects, Biometrika, vol.70, issue.1, pp.41-55, 1983.

, Foundation for Statistical Computing, « A language and environment for statistical computing, 2014.

J. A. Russell and K. R. Walley, et VASST Investigators, « Vasopressin versus norepinephrine infusion in patients with septic shock, N. Engl. J. Med, vol.358, issue.9, pp.877-887, 2008.

J. A. Russell, K. R. Walley, and A. C. Gordon, « Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock, Crit. Care Med, vol.37, issue.3, pp.811-818, 2009.

C. Ertmer, H. Bone, and A. Morelli, Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia », Shock Augusta Ga, vol.27, pp.281-288, 2007.

D. Annane, Vasopressin plus corticosteroids: the shock duo! », vol.37, pp.1126-1127, 2009.

C. Torgersen, M. W. Dünser, and V. Wenzel, « Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial, Intensive Care Med, vol.36, issue.1, pp.57-65, 2010.

M. S. Buckley and R. Maclaren, « Concomitant vasopressin and hydrocortisone therapy on shortterm hemodynamic effects and vasopressor requirements in refractory septic shock, J. Crit. Care, vol.42, pp.6-11, 2017.